603368 柳药集团
2026/09 - 九个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)7.0049.18212.00513.50012.276
总资产报酬率 ROA (%)2.6453.3304.1274.3834.069
投入资产回报率 ROIC (%)3.9004.7315.6255.9755.601

边际利润分析
销售毛利率 (%)10.38511.04711.36611.88911.505
营业利润率 (%)4.0824.2174.7385.0154.672
息税前利润/营业总收入 (%)4.8585.1985.8466.2125.829
净利润/营业总收入 (%)3.4763.4434.0964.3563.984

收益指标分析
经营活动净收益/利润总额(%)101.988104.655101.247104.038104.008
价值变动净收益/利润总额(%)0.171-0.006-0.009-0.0680.832
营业外收支净额/利润总额(%)-1.778-1.430-0.046-0.0290.038

偿债能力分析
流动比率 (X)1.6161.5081.5701.4911.489
速动比率 (X)1.3181.2641.3471.2921.262
资产负债率 (%)59.66461.84362.68364.96165.791
带息债务/全部投入资本 (%)39.20443.27047.51952.51452.370
股东权益/带息债务 (%)147.151124.211104.03284.17184.625
股东权益/负债合计 (%)65.14359.32857.18950.53348.760
利息保障倍数 (X)5.7354.9935.2655.1835.044

营运能力分析
应收账款周转天数 (天)175.469180.960178.818165.680151.143
存货周转天数 (天)58.23454.37247.44346.80645.557